• HOME
  • ABOUT
    • TEAM
  • NEWS
  • STRATEGY
  • PORTFOLIO
  • CONTACT

Pix Vine Capital

PixVC provides early-stage venture capital to startups in the areas of Info-Tech, Med-Tech and Eco-Tech.

  • HOME
  • ABOUT
    • TEAM
  • NEWS
  • STRATEGY
  • PORTFOLIO
  • CONTACT

Proteona, Twist Bioscience to develop neutralizing antibody therapy against COVID-19

June 4, 2020

 

Singapore based Proteona has announced that US headquartered Twist Bioscience will join the international alliance led by Proteona to develop neutralizing antibody therapy against COVID-19 for vulnerable immunocompromised patients.

More from BioSpectrum Asia

 

Filed Under: Uncategorized

© 2023 Pix Vine Capital